Scientists in the US have performed the first personalised gene therapy on a child with a life-threatening rare disease, raising the prospect of similar bespoke treatments for many other disorders.
Researchers and clinicians in Pennsylvania used Crispr gene editing technology to correct a liver cell mutation in the six-month old, who quickly showed signs of better health.
您已閱讀14%（491字），剩余86%（3115字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。